When can a CAP member participate in counterdrug operations?


Before CAP members may participate in counterdrug operations, they must be a senior member, at least 21 years of age, with at least 2 years membership in CAP. Time spent as a cadet may be used to satisfy this two year requirement. For additional requirements please see CAPR 60-6.


2-2. Counterdrug Membership Requirements and Currency.


The authorization to participate in the counterdrug program is a privilege, not a right. Wing CD members participate in the CD program at the discretion of the wing commander as well as the customer. Region CD staff members participate in the CD program at the discretion of the region commander as well as the customer. Every CAP member having access to or knowledge of actual CAP counterdrug missions and mission results must be a qualified CD member


a. Appointment. The wing and region commanders select CAP members to participate in their counterdrug program. CAP members will be selected based on the reasonable certainty that the member is of good character and well motivated. They must be an appropriate representative of Civil Air Patrol in duties subject to high profile scrutiny by law enforcement agencies, Civil Air Patrol and Air Force senior commanders, news media and the general public. The following requirements must be met and maintained before the member may participate:
1) Be ES mission qualified and current in a specialty that has an application with the CD program.
2) Be a senior member, at least 21 years of age, with at least 2 years membership in CAP. Time spent as a cadet may be used to satisfy this requirement.


b. The applicant must complete a CAPF 83, CAP Counterdrug Application, and submit it for review to the wing CDO for wing personnel or region CDD for region staff. Only the most current version of the CAPF 83 will be accepted. This form is a two-sided form, printed on the front and back of a single sheet of paper. Ensure the member has filled in all parts of every box on both sides. The wing CDO reviews, signs and forwards the CAPFs 83 to the wing commander to review member eligibility and for signature. The region CDD reviews, signs and forwards region CAPFs 83 to the region commander to review member eligibility and for signature. The customers require the wing or region commander to be actively involved in the counterdrug application and review process and require a wing or region commander signature on all CAPFs 83. Wing and region commanders will not delegate signatory responsibility for the CAPFs 83. When wing or region commanders submit their own individual CAPF 83, they will sign on the line for the applicant as well as the line for the wing/region commander. The wing CDO will review the wing commander’s CAPF 83 for completeness and sign on the line for the wing CDO. The region CDD will review the region commander’s CAPF 83 for completeness and sign on the line for region CDD. The wing CDO and region CDD submit their CAPFs 83, with original signatures and printed as a two-sided, single-sheet document, to the NHQ CAP Chief, Confidential Screening (NHQ/PMM) for processing.


c. Screening. NHQ CAP/LMMC verifies the applicant’s CAP membership and the completeness of the member information on the CAPF 83, enters the pertinent information into the CD database, and forwards it to the appropriate federal agencies for background screening. If a screening agency disapproves member participation, the individual will not be allowed to participate in the CD program. NHQ CPA/LMMC will notify the appropriate wing CDO (or region CDD for a region staff member) and the member if the screening agency disapproves member participation. The screening agency does not provide the reason they decline the participation. Once the screening agency disapproves counterdrug program participation, the member has no right to appeal and the decision of the agency is final.


d. Orientation. The member must complete the National Counterdrug Orientation course. The member may not complete the National Counterdrug Orientation course until after the screening process has been completed.